This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Choroidal Neovascularization  • Retinal/ Chorioretinal Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

Arch Ophthalmol. 2005;123:1272-1273.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Reichel et al¹ reported the visual results of 16 eyes of 15 patients treated with transpupillary thermotherapy (TTT) with spot sizes of 1.2 mm to 3 mm, and found that 75% of patients had either stabilization or improvement of acuity over a mean follow-up of 13 months. Most patients with occult choroidal neovascularization (CNV),² however, have lesions larger than 3 mm, which is the largest size lesion that can be treated using delivery systems with unitary magnification. Thach et al³ used a lens capable of nearly doubling the treatment spot size for transpupillary thermotherapy, and after 1 year of follow-up, attained by less than half of their patients, most had stable or improved acuity. We examined data from a series of patients with occult subfoveal CNV ranging from greater than 3 mm to less than 4.5 mm in size using a lens providing treatment spot size magnification x 1.5. Our . . . [Full Text of this Article]

Methods


Results

Comment

AUTHOR INFORMATION
Richard F. Spaide, MD; Jason Slakter, MD; Lawrence A. Yannuzzi, MD; John Sorenson, MD; K. Bailey Freund, MD

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?